Featured
-
-
Article
| Open AccessRegional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition
- Chandra C. Ghosh
- , Kara R. Heatherton
- & Steven C. Katz
-
Review Article |
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives
- Vinoth-Kumar Lakshmanan
- , Shlok Jindal
- & Salem Chouaib
-
Article |
Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression
- Aya Hirata
- , Hisayoshi Hashimoto
- & Kazunori Aoki
-
Review |
Immunosuppression in liver tumors: opening the portal to effective immunotherapy
- P Guha
- , J Reha
- & S C Katz
-
-
Original Article |
Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment
- M Zhang
- , L Yan
- & J A Kim